These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1189 related items for PubMed ID: 17940464

  • 1. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
    Meyers MR, Gokce N.
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
    [Abstract] [Full Text] [Related]

  • 2. [Obesity and endothelial dysfunction].
    Taddei S, Ghiadoni L, Salvetti G, Virdis A, Salvetti A.
    G Ital Cardiol (Rome); 2006 Nov; 7(11):715-23. PubMed ID: 17216913
    [Abstract] [Full Text] [Related]

  • 3. Thiazolidinediones-improving endothelial function and potential long-term benefits on cardiovascular disease in subjects with type 2 diabetes.
    Dandona P, Ghanim H, Chaudhuri A, Mohanty P.
    J Diabetes Complications; 2008 Nov; 22(1):62-75. PubMed ID: 18191079
    [Abstract] [Full Text] [Related]

  • 4. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
    Cersosimo E, DeFronzo RA.
    Diabetes Metab Res Rev; 2006 Nov; 22(6):423-36. PubMed ID: 16506274
    [Abstract] [Full Text] [Related]

  • 5. Lifestyle modification and endothelial function in obese subjects.
    Hamdy O.
    Expert Rev Cardiovasc Ther; 2005 Mar; 3(2):231-41. PubMed ID: 15853597
    [Abstract] [Full Text] [Related]

  • 6. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease.
    Caballero AE.
    Obes Res; 2003 Nov; 11(11):1278-89. PubMed ID: 14627747
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance and endothelial cell dysfunction: studies in mammalian models.
    Kearney MT, Duncan ER, Kahn M, Wheatcroft SB.
    Exp Physiol; 2008 Jan; 93(1):158-63. PubMed ID: 17933859
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular disease, metabolic syndrome and erectile dysfunction.
    Müller A, Mulhall JP.
    Curr Opin Urol; 2006 Nov; 16(6):435-43. PubMed ID: 17053524
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular risk and rheumatoid arthritis: from mechanisms of atherosclerosis to therapeutic approach.
    Jurcuţ C, Jurcuţ R, Tănăsescu C.
    Rom J Intern Med; 2004 Nov; 42(4):659-69. PubMed ID: 16366138
    [Abstract] [Full Text] [Related]

  • 10. Adipokines--targeting a root cause of cardiometabolic risk.
    Bakhai A.
    QJM; 2008 Oct; 101(10):767-76. PubMed ID: 18550581
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Obesity and endothelial dysfunction.
    Shankar SS, Steinberg HO.
    Semin Vasc Med; 2005 Feb; 5(1):56-64. PubMed ID: 15968581
    [Abstract] [Full Text] [Related]

  • 17. Assessment of inflammatory markers and endothelial function.
    Järvisalo MJ, Juonala M, Raitakari OT.
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):547-52. PubMed ID: 16912549
    [Abstract] [Full Text] [Related]

  • 18. Adipose tissue dysfunction in obesity.
    Blüher M.
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 60.